Tech Company Financing Transactions

Crescendo Bioscience Funding Round

Safeguard Scientifics, Skyline Ventures and Aeris Capital AG participated in a $28 million Series D funding round for Crescendo Bioscience. The round closed on 1/3/2013.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series D

Safeguard Scientifics (Lead Investor) (Gary Kurtzman)

Skyline Ventures (Lead Investor) (Leon Chen)

Aeris Capital AG

Kleiner Perkins Caufield & Byers (Brook Byers)

Mohr Davidow Ventures (Susan Siegel)

Proceeds Purpose
This round of funding will enable Crescendo to accelerate its commercialization efforts for Vectra DA, a novel test which assesses disease activity in rheumatoid arthritis patients.

Company Information

Company Status
Acquired or Merged
Mailing Address
341 Oyster Point Blvd
South San Francisco, CA 94080
Email Address
Not Recorded
Crescendo Bioscience is developing a broad range of quantitative, objective diagnostic tools to provide Rheumatologists with deeper clinical insights to more effectively manage patients with autoimmune and inflammatory diseases.
Crescendo Bioscience LinkedIn Company Profile
Social Media
Crescendo Bioscience Company Twitter Account
Company News
Crescendo Bioscience News
Crescendo Bioscience on Facebook
Crescendo Bioscience on YouTube

Management Team

Email & Social
Chief Executive Officer
William Hagstrom
  William Hagstrom LinkedIn Profile  William Hagstrom Twitter Account  William Hagstrom News  William Hagstrom on Facebook
Chief Information Officer
Alex Bangs
  Alex Bangs LinkedIn Profile  Alex Bangs Twitter Account  Alex Bangs News  Alex Bangs on Facebook
Chief Medical Officer
Oscar Segurado
  Oscar Segurado LinkedIn Profile  Oscar Segurado Twitter Account  Oscar Segurado News  Oscar Segurado on Facebook
Chief Operating Officer
Brian Bertha
  Brian Bertha LinkedIn Profile  Brian Bertha Twitter Account  Brian Bertha News  Brian Bertha on Facebook
VP - Bus. Development
Lucy Lu
  Lucy Lu LinkedIn Profile  Lucy Lu Twitter Account  Lucy Lu News  Lucy Lu on Facebook
VP - Finance
Timothy Henn
  Timothy Henn LinkedIn Profile  Timothy Henn Twitter Account  Timothy Henn News  Timothy Henn on Facebook
VP - Sales
Erik Harris
  Erik Harris LinkedIn Profile  Erik Harris Twitter Account  Erik Harris News  Erik Harris on Facebook



Browse more venture capital transactions:

Prev: 1/3/2013: Qliance Medical Management venture capital transaction
Next: 1/3/2013: Halt Medical venture capital transaction


Share this article


About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary